PHILADELPHIA — Two neurologists from the Perelman School of Medicine at the University of Pennsylvania have received high honors from the American Academy of Neurology (AAN). The awards will be presented at the American Academy of Neurology’s 66th Annual Meeting in Philadelphia April 26 through May 3 at the Pennsylvania Convention Center.
Parkinson's disease expert Alice Chen-Plotkin, MD, MSc, assistant professor of Neurology, will receive the Jon Stolk Award in Movement Disorders for Young Investigators in recognition for her efforts to establish reliable biomarkers for cognitive and other changes in Parkinson's disease and related neurodegenerative conditions.
Roy Hamilton, MD, MS, assistant professor of Neurology, will receive the Norman Geschwind Prize in Behavioral Neurology for his work on the mechanisms of neuroplacticity. His research has demonstrated the compensatory behavioral response of the brain following stroke, and he is now looking at how interventions such as transcranial magnetic stimulation (TMS) can be used as a biomarker or neurorehabilitative treatments after stroke and other forms of brain injury.
"We are delighted and proud to have two young faculty members receive these prominent awards from the Academy for their research," said Frances Jensen, MD, chair and professor of Neurology in the Perelman School of Medicine. "Both of these clinician-scientists are great examples of collaborative researchers involved in multidisciplinary and translational efforts. Their frontier work, from a cellular and molecular level to real-world applications, has promising clinical potential."
Dr. Hamilton will accept his award as part of Session S28 Aging, Dementia, Cognitive & Behavioral Neurology on Wednesday, April 30, at 2 p.m. Dr. Chen-Plotkin will receive her award on Thursday, May 1, at 1 p.m. during Session S44: Movement Disorders: Huntington’s Disease, Ataxia, and Wilson’s Disease. For more information on the awards, please visit the AAN Press Room online
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.